Clinical Trial Update: Engineered Immune Effectors Against Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on engineered immune effectors for ovarian cancer spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: UNKNOWN